ICKSH 2024

[JS01] Joint Session 01: Asian hematology session I - EBV-associated lymphoid malignancy Room 1

March 28 (Thursday), 09:00-10:15
Ki Seong Eom (The Catholic University of Korea College of Medicine, Korea), Dok Hyun Yoon (University of Ulsan College of Medicine, Korea)
09:00-09:25 Prospective studies for NK/T-cell lymphoma in Asia Seok Jin Kim (Sungkyunkwan University School of Medicine, Korea) 09:25-09:50 Chronic active EBV disease: Our challenge to elucidate the pathogenesis Ayako Arai (St. Marianna University School of Medicine, Japan) 09:50-10:15 NK lymphoma genomics Weili Zhao (Shanghai Jiao Tong University School of Medicine, China)

[ES01] Education Session 01: Histiocytic neoplasm Room 2

March 28 (Thursday), 09:00-10:15
Nack-Gyun Chung (The Catholic University of Korea College of Medicine, Korea), Hyoung Soo Choi (Seoul National University College of Medicine, Korea)
09:00-09:25 Histiocytic neoplasm in pediatrics Kyung-Nam Koh (University of Ulsan College of Medicine, Korea) 09:25-09:50 Histiocytic sarcoma Sungnam Lim (Inje University College of Medicine, Korea) 09:50-10:15 Pathologic characteristics of histiocytic neoplasm Sun Och Yoon (Yonsei University College of Medicine, Korea)

[SS01] Scientific Session 01: Exploring the utilization of innovative technologies Room 3

March 28 (Thursday), 09:00-10:15
Young Kyung Lee (Hallym University College of Medicine, Korea), Yoon Hwan Chang (Seoul National University College of Medicine, Korea)
09:00-09:25 Elucidating the 3D chromatin landscape of pediatric B-cell acute lymphoblastic leukemia using Micro-C Kajsa Paulsson (Lund University, Sweden) 09:25-09:50 Integrated RNA and protein profiling of B-cell acute lymphoblastic leukemia at single-cell level Sungyoung Choi (Hanyang University College of Medicine, Korea) 09:50-10:15 Leveraging dysregulated signaling networks for therapeutic benefit in myeloproliferative neoplasm Stephen T. Oh (Washington University School of Medicine, USA)

[SS02] Scientific Session 02: The unmet needs in CML - Overcoming the obstacles of the road to cure Room 4

March 28 (Thursday), 09:00-10:15
Chul Won Jung (Sungkyunkwan University School of Medicine, Korea), Hawk Kim (Gachon University College of Medicine, Korea)
09:00-09:25 Molecular mechanism of primary TKI resistance in CML Jerald Radich (Fred Hutchinson Cancer Center, USA) 09:25-09:50 Targeting leukemic stem cells in CML Mhairi Copland (University of Glasgow, UK) 09:50-10:15 The role of NGS to detect TKI resistance Saeam Shin (Yonsei University College of Medicine, Korea)

[PL01] Plenary Lecture 01 Room 1+2

March 28 (Thursday), 10:30-11:15
Seoklae Chae (Dongguk University College of Medicine, Korea)
10:30-11:15 Somatic mutations and clonal dynamics in human blood cells Peter J. Campbell (Wellcome Sanger Institute, UK)

[PS01] Presidential Symposium 01 Room 1+2

March 28 (Thursday), 11:15-12:00
Seongsoo Jang (University of Ulsan College of Medicine, Korea)
11:15–12:00 Lab-on-a-chip in hematology Chong H. Ahn (University of Cincinnati, USA)

[SY01] Satellite Symposium 01: Janssen Room 1

March 28 (Thursday), 12:15-13:05
Kihyun Kim (Sungkyunkwan University School of Medicine, Korea)
12:15-13:05 Treatment of newly diagnosed multiple myeloma: Focus on daratumumab combination Elena Zamagni (IRCCS Azienda Ospedaliero-Universitaria di Bologna, Italy)

[SY02] Satellite Symposium 02: Astrazeneca Room 2

March 28 (Thursday), 12:15-13:05
Jun Ho Jang (Sungkyunkwan University School of Medicine, Korea)
12:15-13:05 The ultimate value of C5 inhibitors in the evolving treatment landscape of PNH Sung-Hyun Kim (Dong-A University College of Medicine, Korea)

[SY03] Satellite Symposium 03: Astellas Room 3

March 28 (Thursday), 12:15-13:05
Hee-Je Kim (The Catholic University of Korea College of Medicine, Korea)
12:15-13:05 Treatment strategies for elderly AML with FLT3-mutation, entering the era of FLT3 Inhibitors Naoko Hosono (University of Fukui, Japan)

[SY04] Satellite Symposium 04: Roche Room 4

March 28 (Thursday), 12:15-13:05
Sung-Soo Yoon (Seoul National University College of Medicine, Korea)
12:15-13:05 Advances in the treatment paradigm with bispecific antibodies Wendy Osborne (Newcastle University, UK)

[JS02] Joint Session 02: EHA-KSH Joint Symposium - Multiple Myeloma Room 1

March 28 (Thursday), 15:30-16:45
Jin Seok Kim (Yonsei University College of Medicine, Korea), Meral Beksac (Ankara Liv Hospital, Türkiye)
15:30-15:46 Dynamic assessment of risk in multiple myeloma Meral Beksac (Ankara Liv Hospital, Türkiye) 15:46-16:02 PET/CT for risk stratification in multiple myeloma Joon Ho Moon (Kyungpook National University School of Medicine, Korea) 16:02-16:18 Bone marrow inflammation in multiple myeloma Tom Cupedo (Erasmus MC Cancer Center, The Netherlands) 16:18-16:34 Single-cell analysis in multiple myeloma Sung-Soo Park (The Catholic University of Korea College of Medicine, Korea)

[SS03] Scientific Session 03: Wise perspective on new approaches in hemophilia Room 2

March 28 (Thursday), 15:30-16:45
Eun Jin Choi (Daegu Catholic University School of Medicine, Korea), Young Shil Park (Kyung Hee University College of Medicine, Korea)
15:30-15:55 Approaches to treat people with hemophilia: What’s new and what’s not? Leonard Valentino (The National Bleeding Disorders Foundation (NBDF) , USA) 15:55-16:20 Prospects and challenges of gene therapy for hemophilia Alok Srivastava (Christian Medical College, India) 16:20-16:45 Exploring personalized tailored hemophilia treatment Jeong A Park (Inha University College of Medicine, Korea)

[SS04] Scientific Session 04: For the next generation CAR-T cells Room 3

March 28 (Thursday), 15:30-16:45
Seok-Goo Cho (The Catholic University of Korea College of Medicine, Korea), Je-Jung Lee (Chonnam National University Medical School, Korea)
15:30-15:55 CD7 CAR-T therapy for treating hematological maligancies Peihua Lu (Lu Daopei Hospital, China) 15:55-16:20 Development of a novel anti-CD19 CAR-T cells in B cell lymphoma Dok Hyun Yoon (University of Ulsan College of Medicine, Korea) 16:20-16:45 CAR T cells for treatment of T cell malignancies Paul M. Maciocia (Cancer Research UK , UK)

[SS05] Scientific Session 05: Deepened understanding of AML using multi-omics approaches Room 4

March 28 (Thursday), 15:30-16:45
Hyeoung-Joon Kim (Chonnam National University Medical School, Korea), Myung-Shin Kim (The Catholic University of Korea College of Medicine, Korea)
15:30-15:55 Navigating cancer complexities via single-cell omics and AI Manoj Bhasin (Emory University, USA) 15:55-16:20 Targeting the developmental heterogeneity of human acute myeloid leukemia Shanshan Pei (Zhejiang University, China) 16:20-16:45 Mutational profile in Korean AML patients Jae-Sook Ahn (Chonnam National University Medical School, Korea)

[SS06] Scientific Session 06: Insights into lymphoma pathobiology Room 1

March 28 (Thursday), 16:55-18:10
Seok Jin Kim (Sungkyunkwan University School of Medicine, Korea), Gyeong-Sin Park (The Catholic University of Korea College of Medicine, Korea)
16:55-17:20 Germinal center in the genesis of lymphomas Laura Pasqualucci (Columbia University, USA) 17:20-17:45 Genomics of follicular lymphoma: Clinical implications? Robert Kridel (University Health Network, Canada) 17:45-18:10 Distinct and overlapping features of nodal peripheral T-cell lymphomas exhibiting a follicular helper T-cell phenotype: a multicenter study emphasizing the clinicopathological significance of follicular helper T-cell marker expression Jin Ho Paik (Seoul National University College of Medicine, Korea)

[SS07] Scientific Session 07: Profound understanding of diagnosis and therapy in MDS Room 2

March 28 (Thursday), 16:55-18:10
Yoo Jin Kim (The Catholic University of Korea College of Medicine, Korea), Jun Ho Jang (Sungkyunkwan University School of Medicine, Korea)
16:55-17:20 Molecular alterations and clinical implications in MDS Yasushi Miyazaki (Nagasaki University, Japan) 17:20-17:45 Recent advances and future therapeutic strategies in MDS Guillermo Garcia-Manero (The University of Texas MD Anderson Cancer Center, USA) 17:45-18:10 Current diagnostic challenges of MDS In-Suk Kim (Pusan National University Yangsan Hospital, Korea)

[SS08] Scientific Session 08: Leukemogenesis in children and adults Room 3

March 28 (Thursday), 16:55-18:10
Kyung Ha Ryu (Ewha Womans University College of Medicine, Korea), Hoon Kook (Chonnam National University Medical School, Korea)
16:55-17:20 RUNX1-FPDMM natural history study at NIH Pu Paul Liu (National Institutes of Health, USA) 17:20-17:45 Clinical impact of DDX41 mutations in myeloid neoplasms Talha Badar (Mayo Clinic, USA) 17:45-18:10 Discovery of new regulators in hematopoietic stem cells and malignancies Dongjun Lee (Pusan National University School of Medicine, Korea)

[ES02] Education Session 02: Basics for trainees (Kor) Room 4

March 28 (Thursday), 16:55-18:10
Inho Kim (Seoul National University College of Medicine, Korea), Jaewoo Song (Yonsei University College of Medicine, Korea)
16:55-17:20 Overview of lymphoma classification Tae-Jung Kim (The Catholic University of Korea College of Medicine, Korea) 17:20-17:45 What's new in AML classification Hee Sue Park (Chungbuk National University College of Medicine, Korea) 17:45-18:10 Recent update of MDS classification MiYoung Kim (University of Ulsan College of Medicine, Korea)

[JS03] Joint Session 03: ASH-KSH Joint Symposium - Ped-ALL Room 1

March 29 (Friday), 09:00-10:15
Keon Hee Yoo (Sungkyunkwan University School of Medicine, Korea), Wendy Stock (University of Chicago, USA)
09:00-09:16 Pediatric and AYA ALL: Lessons learned from children’s oncology group clinical trials Sarah K. Tasian (The Children’s Hospital of Philadelphia, USA) 09:16-09:32 Multicenter trials investigating childhood acute lymphoblastic leukemia in South Korea Hyery Kim (University of Ulsan College of Medicine, Korea) 09:32-09:48 Dissecting the Developmental Origins of Acute Leukemia Charles G. Mullighan (St. Jude Children’s Research Hospital, USA) 09:48-10:04 Unveiling precision medicine: RNA and DNA sequencing in targeted therapy for Korean pediatric leukemia Myung-Shin Kim (The Catholic University of Korea College of Medicine, Korea)

[ES03] Education Session 03: Leaps and hurdles in transfusion medicine (Kor) Room 2

March 29 (Friday), 09:00-10:15
Duck Cho (Sungkyunkwan University School of Medicine, Korea), Jihyang Lim (The Catholic University of Korea College of Medicine, Korea)
09:00-09:25 Comprehensive overview of cell-based artificial platelet production Seung Yeob Lee (Jeonbuk National University Medical School, Korea) 09:25-09:50 Anti-CD38 and anti-CD47 delay timely transfusion Hyungsuk Kim (Seoul National University College of Medicine, Korea) 09:50-10:15 Reappraisal of transfusion-transmitted infections Dae-Hyun Ko (University of Ulsan College of Medicine, Korea)

[SS09] Scientific Session 09: Clonal hematopoiesis: What should we know? Room 3

March 29 (Friday), 09:00-10:15
Myung Geun Shin (Chonnam National University Medical School, Korea), Hyun Kyung Kim (Seoul National University College of Medicine, Korea)
09:00-09:25 Clonal hematopoiesis and aging Siddhartha Jaiswal (Stanford University School of Medicine, USA) 09:25-09:50 Clonal hematopoiesis: Implications for cell therapy Adam S. Sperling (Dana-Farber Cancer Institute, USA) 09:50-10:15 Clonal Hematopoiesis and Metabolic Disorders Sung Hee Choi (Seoul National University College of Medicine, Korea)

[SS10] Scientific Session 10: Predictive biomarkers in multiple myeloma Room 4

March 29 (Friday), 09:00-10:15
Chang-Ki Min (The Catholic University of Korea College of Medicine, Korea), Jeong Yeal Ahn (Gachon University College of Medicine, Korea)
09:00-09:25 The impact of immune profiling of T-cell and plasma cells on non-cellular immune therapy in myeloma Nizar J Bahlis (University of Calgary, Canada) 09:25-09:50 Single-cell techniques to characterize immune microenvironment in MM Niels Weinhold (Univ Hosp Heidelberg, Germany) 09:50-10:15 The power of ONE: Immunology in the age of single cell genomics Ido Amit (Weizmann Institute of Science, Israel)

[PL02] Plenary Lecture 02 Room 1+2

March 29 (Friday), 10:30-11:15
Chuhl Joo Lyu (Yonsei University College of Medicine, Korea)
10:30–11:15 How to win: Competitive strategies in the hematopoietic stem cell niche Margaret Goodell (Baylor College of Medicine, USA)

[SY05] Satellite Symposium 05: BMS Room 1

March 29 (Friday), 12:15-13:05
Je-Hwan Lee (University of Ulsan College of Medicine, Korea)
12:15-13:05 Continued hope with ONUREG - A new maintenance therapy to treat AML Esther Oliva (Grande Ospedale Metropolitano Bianchi Melacrino Morelli)

[SY06] Satellite Symposium 06: Kyowa Kirin Room 2

March 29 (Friday), 12:15-13:05
Won Seog Kim (Sungkyunkwan University School of Medicine, Korea)
12:15-13:05 Mogamulizumab: A new era in MF/SS management - Clinical evidence and practical consideration Francine Foss (Yale University School of Medicine)

[SY07] Satellite Symposium 07: Novartis Room 3

March 29 (Friday), 12:15-13:05
Dong-Wook Kim (Eulji University School of Medicine, Korea)
12:15-13:05 TKI treatment pattern and new therapy of CML Qian Jiang (Peking University People's Hospital)

[SY08] Satellite Symposium 08: Handok Room 4

March 29 (Friday), 12:15-13:05
Hyeon-Seok Eom (National Cancer Center, Korea)
12:15-13:05 The optimal treatment strategy for transplant-ineligible relapsed/refractory DLBCL Kwai Han Yoo (Gachon University College of Medicine)

[JS04] Joint Session 04: Current interests in hematologic disease in Asia Room 1

March 29 (Friday), 15:05-16:20
Soo-Mee Bang (Seoul National University College of Medicine, Korea), Byeong-Bae Park (Hanyang University College of Medicine, Korea)
15:05-15:25 The journey of bone marrow transplantation at BachMai General Hospital Han Viet Trung (Journey of transplantation in Bach Mai General Hospital, Vietnam) 15:25-15:45 Current situation of management of non-hodgkin lymphoma in the Republic of Armenia Yervand Hakobyan (Armenian Hematology Association, Armenia) 15:55-16:20 The evolution of hemophilia treatment in Thailand Darintr Sosothikul (Chulalongkorn University, Thailand)

[SS11] Scientific Session 11: Quality-of-life revisited Room 2

March 29 (Friday), 15:05-16:20
Sung Yong Oh (Dong-A University College of Medicine, Korea), Yong Park (Korea University College of Medicine, Korea)
15:05-15:30 End-of-life care in children with hematologic malignancies Min Sun Kim (Seoul National University College of Medicine, Korea) 15:30-15:55 Long-term survivorship in hematologic malignancies Shahrukh K. Hashmi (Mayo Clinic, USA) 15:55-16:20 The importance of monitoring symptoms and quality of life in routine hematology practice Fabio Efficace (Italian Group for Adult Hematologic Diseases, Italy)

[SS12] Scientific Session 12: Novel approaches for diagnosis & treatment of acute lymphoblastic leukemia Room 3

March 29 (Friday), 15:05-16:20
Hyoung Jin Kang (Seoul National University College of Medicine, Korea), Ho-Jin Shin (Pusan National University School of Medicine, Korea)
15:05-15:30 Novel approaches for diagnosis & treatment of acute lymphoblastic and myeloid leukemia Michel Zwaan (Princess Ma´xima Center for Pediatric Oncology, The Netherlands) 15:30-15:55 The role of blinatumomab in the treatment of MRD negative B-ALL in adults Mark R. Litzow (Mayo Clinic, USA) 15:55-16:20 Revised WHO classification of ALL: New era of genetic diagnosis Ari Ahn (The Catholic University of Korea College of Medicine, Korea)

[ES04] Education Session 04: Monoclonal gammopathies of clinical significance Room 4

March 29 (Friday), 15:05-16:20
Young Rok Do (Keimyung University School of Medicine, Korea), Hyo Jung Kim (Hallym University College of Medicine, Korea)
15:05-15:30 AL cardiac amyloidosis Darae Kim (Sungkyunkwan University School of Medicine, Korea) 15:30-15:55 Nephrologist’s perspective on monoclonal gammopathy of renal significance Soon Hyo Kwon (Soonchunhyang University College of Medicine, Korea) 15:55-16:20 Monoclonal gammopathies of neurological significance Ju-Hong Min (Sungkyunkwan University School of Medicine, Korea)

[SS13] Scientific Session 13: Advancing in knowledge of rare pediatric hematologic disorders Room 2

March 29 (Friday), 16:35-17:50
Ho Joon Im (University of Ulsan College of Medicine, Korea), Hye Lim Jung (Sungkyunkwan University School of Medicine, Korea)
16:35-17:00 Clonal evolution of MDS/AML in patients with cancer predisposition syndromes Kenichi Yoshida (National Cancer Center Research Institute, Japan) 17:00-17:25 Congenital & aquired thrombophilic conditions in children Leonardo R. Brandão (University of Toronto, Canada) 17:25-17:50 Management of rare pediatric lymphomas Jae Wook Lee (The Catholic University of Korea College of Medicine, Korea)

[JS05] Joint Session 05: Asian Hematology Session II - AML Room 3

March 29 (Friday), 16:35-17:50
Sangkyun Sohn (Kyungpook National University School of Medicine, Korea), Byong Soo Kim (Korea University College of Medicine, Korea)
16:35-16:55 Epidemiology, risk stratification and treatment outcome in acute myeloid treatment: Taiwan experience Hsin-An Hou (National Taiwan University, Taiwan) 16:55-17:15 Advancement in leukaemia diagnostics: the role of next-generation sequencing (NGS) in acute myeloid leukaemia in Malaysia Angeli Ambayya (Ministry of Health, Malaysia) 17:15-17:35 Determining fitness for treatments in older adults with AML Byung Sik Cho (The Catholic University of Korea College of Medicine, Korea)

[ES05] Education Session 05: Principles of anticoagulation - All about blood clots (Kor) Room 4

March 29 (Friday), 16:35-17:50
Soo-Mee Bang (Seoul National University College of Medicine, Korea), Sung Hwa Bae (Daegu Catholic University School of Medicine, Korea)
16:35-17:00 Back to the basic: coagulation pathway Seonyang Park (Inje University Haeundae Paik Hospital, Korea) 17:00-17:25 Pharmacology: Anticoagulants and reversal agents Seo-Yeon Ahn (Chonnam National University College of Medicine, Korea) 17:25-17:50 Proper application of anticoagulation therapy on CAT Ho-Young Yhim (Jeonbuk National University Medical School, Korea)

[ES06] Education Session 06: Essential knowledge for optimal hematologic consultation (Kor) Room 1

March 30 (Saturday), 09:00-10:15
Jong Ho Won (Soonchunhyang University College of Medicine, Korea), Deog-Yeon Jo (Chungnam National University College of Medicine, Korea)
09:00-09:25 Functional iron deficiency in cancer patients Ik-Chan Song (Chungnam National University Medical School, Korea) 09:25-09:50 Assessment of neutropenia in hospitalized patients Young Hoon Park (Ewha Womans University College of Medicine, Korea) 09:50-10:15 Perioperative consultation for the appropriate transfusion Ka-Won Kang (Korea University College of Mecine, Korea)

[SS14] Scientific Session 14: Novel insights into pathogenesis of MPN Room 2

March 30 (Saturday), 09:00-10:15
Chul Won Choi (Korea University College of Mecine, Korea), Sung-Yong Kim (Konkuk University School of Medicine, Korea)
09:00-09:25 Myeloproliferative neoplasms and inflammation Steffen Koschmieder (RWTH Aachen University, Germany) 09:25-09:50 Signaling contributing to the development of myelofibrosis: Beyond JAK/STAT Douglas Tremblay (Mount Sinai School of Medicine, USA) 09:50-10:15 Clonal evolution in myelofibrosis Sung-Eun Lee (The Catholic University of Korea College of Medicine, Korea)

[SS15] Scientific Session 15: Immunotherapies for lymphomas non-benefited from CAR-T cell therapy Room 3

March 30 (Saturday), 09:00-10:15
Jae-Yong Kwak (Jeonbuk National University Medical School, Korea), Deok-Hwan Yang (Chonnam National University Medical School, Korea)
09:00-09:25 Treatment options for relapsed/refractory hodgkin lymphoma after brentuximab vedotin and PD-1 blockade Alex F. Herrera (City of Hope, USA) 09:25-09:50 Aggressive B-cell lymphomas: Immuno-chemotherapies other than CAR-T cell therapies Jason Westin (MD Anderson Cancer Center, USA) 09:50-10:15 Extranodal NK/T cell lymphoma: the immunogenic tumor Won Seog Kim (Sungkyunkwan University School of Medicine, Korea)

[ES07] Education Session 07: Basic genomics for clinical hematologists (Kor) Room 4

March 30 (Saturday), 09:00-10:15
Hee-Jin Kim (Sungkyunkwan University School of Medicine, Korea), In-Suk Kim (Pusan National University Yangsan Hospital, Korea)
09:00-09:25 Genomic technologies for detecting structural variations in hematologic malignancies Mi-Ae Jang (Sungkyunkwan University School of Medicine, Korea) 09:25-09:50 The role of NGS in hematologic malignancies Young-Uk Cho (University of ulsan College of Medicine, Korea) 09:50-10:15 Germline predisposition to hematologic malignancies Sang Mee Hwang (Seoul National University College of Medicine, Korea)

Scientific Program

March 28 (Thursday)

March 29 (Friday)

March 30 (Saturday)

Sponsored by